Last Update 06 Jul 26
Fair value Increased 7.43%EPC: Takeover Rejection And Index Inclusion Will Support Future Upside Potential
Analysts have raised their price target on Edgewell Personal Care from $31.40 to $33.73, reflecting updated assumptions around discount rates, projected revenue trends, profit margins, and future P/E levels.
What’s in the News for Edgewell Personal Care
- Edgewell Personal Care rejected an unsolicited US$30 per share takeover offer from private equity firm Yellow Wood Partners, with the board stating the proposal undervalued the company relative to its view of long term potential. Source: recent news reports.
- The US$30 offer represented a premium to Edgewell Personal Care’s prior trading price around US$25, but the company chose to remain independent, signaling confidence in its own plan. Source: recent news reports.
- Following the rejection of the bid, Edgewell Personal Care shares moved higher in after hours and early trading, with reports citing gains in the 10% to nearly 14% range. Source: recent news reports.
- Edgewell Personal Care was added to the Russell 2000 Dynamic Index, which can influence how index linked funds and other benchmarked investors view and potentially hold the stock. Source: Key Developments.
- Edgewell Personal Care updated its full fiscal year 2026 outlook, guiding reported net sales to an expected increase of about 0.8% to 3.8% and GAAP EPS to a range of flat to US$0.40 per share, with the change tied to higher estimated restructuring, related costs, and legal matters. Source: Key Developments.
Valuation Changes for Edgewell Personal Care
- Fair Value: The updated estimate has risen from $31.40 to $33.73 per share, a modest upward revision in the valuation model.
- Discount Rate: The assumed discount rate has fallen significantly from 10.67% to 8.99%, indicating a lower required return in the updated analysis.
- Revenue Growth: The long term revenue growth assumption has shifted from an expected increase of 1.88% to a decline of 3.16%, reflecting a more cautious top line outlook.
- Net Profit Margin: The forecast net profit margin has been raised sharply from 9.37% to 32.31%, implying a much higher expected level of profitability in the model.
- Future P/E: The assumed future P/E multiple has been reduced from 7.9x to 2.9x, suggesting a lower valuation multiple applied to projected earnings.
Key Takeaways
- International strength, margin improvements from productivity, and modernized U.S. operations position Edgewell for outsized revenue and earnings growth despite macro headwinds.
- Digital expansion and favorable industry trends support sustained demand, higher margins, and long-term market share gains across diverse consumer segments.
- Weak core category performance, rising competition, regulatory pressures, and shifting consumer habits threaten Edgewell's revenue growth, margins, and ability to innovate for long-term success.
Catalysts
About Edgewell Personal Care- Manufactures and markets personal care products worldwide.
- Analyst consensus is underestimating Edgewell's sustained trajectory of international outperformance: with 40% of global sales internationally and a multi-year record of mid
- to high single-digit organic growth, Edgewell is poised for outsized revenue and earnings expansion as its international business approaches scale, supported by successful pricing power, resilient brand positioning, and further penetration into rapidly growing emerging markets.
- While analysts broadly agree that supply chain optimization and cost controls are driving margin improvements, the full impact of accelerated productivity savings-consistently delivering 250 to 300 basis points in gross margin tailwind per year-has not been embedded; given the company's proven execution and continued investments, net margin and free cash flow could inflect materially higher as these structural savings compound and offset macro headwinds.
- Edgewell's reinvigorated U.S. commercial organization, with a new leadership team, is laying the foundation for a step-change in North American performance; this massive operational overhaul, along with a focused shift to modern brand-building and consumer engagement, sets up the U.S. business for a multi-year acceleration in revenue and market share, especially as market share gains are already visible in brands like Cremo and Hawaiian Tropic.
- The company's moves to scale its direct-to-consumer and omni-channel go-to-market models are gaining traction, with recent high-ROI digital campaigns (notably on Amazon) and successful product launch execution demonstrating Edgewell's ability to capture both higher-margin online sales and resilient demand among younger, digitally engaged consumers-directly fueling top-line growth and margin expansion.
- Long-term industry and demographic tailwinds, such as the rising global middle class, increased health and hygiene awareness, and expansion of the male grooming category, provide a powerful secular backdrop; Edgewell's brand portfolio and innovation pipeline are well positioned to tap into these trends, creating robust, sustained demand that will drive above-consensus revenue and earnings growth over the coming decade.
Edgewell Personal Care Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- This narrative explores a more optimistic perspective on Edgewell Personal Care compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
- The bullish analysts are assuming Edgewell Personal Care's revenue will decrease by 3.2% annually over the next 3 years.
- The bullish analysts assume that profit margins will increase from -0.5% today to 32.3% in 3 years time.
- The bullish analysts expect earnings to reach $655.5 million (and earnings per share of $3.12) by about July 2029, up from -$10.5 million today. The analysts are largely in agreement about this estimate.
- In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 3.0x on those 2029 earnings, up from -117.0x today. This future PE is lower than the current PE for the US Personal Products industry at 19.0x.
- The bullish analysts expect the number of shares outstanding to decline by 0.82% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.99%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Persistent weakness in Edgewell's North American business, including significant declines in Sun Care and ongoing volume and promotional pressure in core categories like Wet Shave and Fem Care, could lead to structurally lower revenue growth and sustained margin compression.
- Elevated competitive intensity from private label and indie brands, along with highly promotional activity in the women's shave space, threatens Edgewell's pricing power and brand equity, which may result in eroding market share and declining revenues.
- The company's reliance on weather-dependent categories such as Sun Care, combined with increased regulatory risks related to ingredients and heightened consumer preference for natural or sustainable products, raises the risk of lower category volumes and increased compliance costs, negatively affecting both sales and profit margins over time.
- Ongoing macroeconomic and operational headwinds, including volatile tariffs, unfavorable foreign exchange, and persistent inventory challenges, are already reducing free cash flow and net earnings, suggesting limited financial flexibility to fund R&D, innovation, or strategic acquisitions essential for long-term growth.
- Demographic and secular shifts-such as declining shaving frequency among younger consumers and changing gender norms-combined with Edgewell's continued dependence on legacy shaving products and limited breakthrough innovation, put future gross margins and earnings at risk due to a shrinking addressable market and stalled portfolio diversification.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The assumed bullish price target for Edgewell Personal Care is $33.73, which represents up to two standard deviations above the consensus price target of $24.83. This valuation is based on what can be assumed as the expectations of Edgewell Personal Care's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $34.0, and the most bearish reporting a price target of just $21.0.
- In order for you to agree with the more bullish analyst cohort, you'd need to believe that by 2029, revenues will be $2.0 billion, earnings will come to $655.5 million, and it would be trading on a PE ratio of 3.0x, assuming you use a discount rate of 9.0%.
- Given the current share price of $26.67, the analyst price target of $33.73 is 20.9% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Edgewell Personal Care?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystHighTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystHighTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystHighTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.